EP2132204 - CRYSTALLINE FORMS OF AN 8-AZABICYCLO[3.2.1]OCTANE COMPOUND [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 29.11.2013 Database last updated on 26.07.2024 | Most recent event Tooltip | 24.01.2014 | Change - lapse in a contracting state State(s) deleted from list of lapses: CY | published on 26.02.2014 [2014/09] | Applicant(s) | For all designated states Theravance, Inc. 901 Gateway Boulevard South San Francisco, CA 94080 / US | [2009/51] | Inventor(s) | 01 /
DALZIEL, Sean 201 Harrison Street 921 San Francisco, California 94105 / US | 02 /
PREZA, Leticia M. 69 Nordhoff Street San Francisco, California 94131 / US | 03 /
RAPTA, Miroslav 411 E. Duane Avenue Sunnyvale, California 94085 / US | 04 /
COLSON, Pierre-Jean 301 Bryant Street 403 San Francisco, California 94107 / US | [2009/51] | Representative(s) | Scott, Susan Margaret Abel & Imray 20 Red Lion Street London WC1R 4PQ / GB | [N/P] |
Former [2013/04] | Scott, Susan Margaret Abel & Imray 20 Red Lion Street London WC1R 4PQ / GB | ||
Former [2009/51] | Scott, Susan Margaret Abel & Imray 20 Red Lion Street London WC1R 4PQ / GB | Application number, filing date | 08726162.4 | 27.02.2008 | [2009/51] | WO2008US02583 | Priority number, date | US20070904090P | 28.02.2007 Original published format: US 904090 P | [2009/51] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2008106159 | Date: | 04.09.2008 | Language: | EN | [2008/36] | Type: | A1 Application with search report | No.: | EP2132204 | Date: | 16.12.2009 | Language: | EN | The application published by WIPO in one of the EPO official languages on 04.09.2008 takes the place of the publication of the European patent application. | [2009/51] | Type: | B1 Patent specification | No.: | EP2132204 | Date: | 23.01.2013 | Language: | EN | [2013/04] | Search report(s) | International search report - published on: | EP | 04.09.2008 | Classification | IPC: | C07D451/02, A61K31/46 | [2009/51] | CPC: |
A61K31/46 (EP,KR,US);
C07D451/02 (EP,KR,US);
A61K31/485 (EP,US);
A61K45/06 (US);
A61P1/00 (EP);
A61P1/04 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2009/51] | Title | German: | KRISTALLINE FORMEN EINER 8-AZABICYCLO[3.2.1]OCTANVERBINDUNG | [2009/51] | English: | CRYSTALLINE FORMS OF AN 8-AZABICYCLO[3.2.1]OCTANE COMPOUND | [2009/51] | French: | FORMES CRISTALLINES D'UN COMPOSÉ 8-AZABICYCLO[3.2.1]OCTANE | [2009/51] | Entry into regional phase | 25.09.2009 | National basic fee paid | 25.09.2009 | Designation fee(s) paid | 25.09.2009 | Examination fee paid | Examination procedure | 25.09.2009 | Amendment by applicant (claims and/or description) | 25.09.2009 | Examination requested [2009/51] | 09.02.2011 | Despatch of a communication from the examining division (Time limit: M04) | 03.06.2011 | Reply to a communication from the examining division | 06.08.2012 | Communication of intention to grant the patent | 13.12.2012 | Fee for grant paid | 13.12.2012 | Fee for publishing/printing paid | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 09.02.2011 | Opposition(s) | 24.10.2013 | No opposition filed within time limit [2014/01] | Fees paid | Renewal fee | 24.02.2010 | Renewal fee patent year 03 | 23.02.2011 | Renewal fee patent year 04 | 24.02.2012 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | deleted | [2014/09] |
Former [2013/52] | CY | 23.01.2013 | Cited in | International search | [A]WO2004089909 (PFIZER PROD INC [US], et al) [A] 1,13,21,23 * page 1, paragraph 1 * * claim 1 *; | [A]WO2004089908 (PFIZER PROD INC [US], et al) [A] 1,13,21,23 * page 1, paragraph 1 ** claim 1 *; | [XP]WO2007103187 (THERAVANCE INC [US], et al) [XP] 1,13,21,23 * examples 58A,58B * |